Short answer · Medically reviewed summary · Last updated: 2026-04-06
Most cases of Myasthenia Gravis are not hereditary, as the condition is typically an acquired autoimmune disorder rather than a directly inherited genetic disease. Understanding the Genetic Component While the vast majority of Myasthenia Gravis cases occur sporadically, there is an important distinction between autoimmune Myasthenia Gravis and the rare, inherited group of disorders known as Congenital Myasthenic Syndromes (CMS). In typical autoimmune Myasthenia Gravis, the body’s immune system mistakenly attacks receptors at the neuromuscular junction.
2 people with Myasthenia Gravis have shared their first-person experience on this question at DiseaseMaps.
Most cases of Myasthenia Gravis are not hereditary, as the condition is typically an acquired autoimmune disorder rather than a directly inherited genetic disease.
While the vast majority of Myasthenia Gravis cases occur sporadically, there is an important distinction between autoimmune Myasthenia Gravis and the rare, inherited group of disorders known as Congenital Myasthenic Syndromes (CMS). In typical autoimmune Myasthenia Gravis, the body’s immune system mistakenly attacks receptors at the neuromuscular junction. While genetic factors may increase a person’s susceptibility to developing autoimmune conditions, it is not passed down through a simple Mendelian inheritance pattern like autosomal dominant or recessive traits.
Congenital Myasthenic Syndromes (CMS) are distinct from autoimmune Myasthenia Gravis; these are true genetic disorders caused by mutations in specific genes that affect the structure or function of the neuromuscular junction. CMS follows various inheritance patterns, most commonly autosomal recessive. If a family has a confirmed diagnosis of a genetic CMS, the recurrence risk for siblings can be as high as 25%. However, for the typical autoimmune form, the risk of a child developing the disease from an affected parent is very low and not easily quantified by standard genetic risk percentages.
Genetic testing is not routinely recommended for patients with typical autoimmune Myasthenia Gravis. Testing is primarily reserved for patients who show symptoms very early in life or do not respond to standard immunosuppressive therapies, as this may point toward a diagnosis of CMS. For families concerned about hereditary risks, genetic counseling is highly valuable. A counselor can help distinguish between autoimmune susceptibility and rare genetic syndromes, providing clarity for family planning and prenatal considerations.
Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.